0000000000305917
AUTHOR
Damián García-olmo
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
The Collaborative Working Group “Noma Project Team”.
Histopathological analysis of human specimens removed from the injection area of expanded adipose-derived stem cells
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
On behalf of TerCel
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
[This corrects the article DOI: 10.3389/fimmu.2019.01151.].